Latest / Women's Health / 8.31.26
Transcript
- 0:02Speaker 1: Welcome to Women's Health Corner for Radio Eye. As a reminder,
- 0:05Speaker 1: Radio Eye is a reading service intended for people who
- 0:09Speaker 1: are blind or have other disabilities that make it difficult
- 0:12Speaker 1: to read printed material. The health material presented in this
- 0:16Speaker 1: program is provided for your interest and information. It is
- 0:20Speaker 1: not intended for the diagnosis or treatment of individuals. Please
- 0:25Speaker 1: see your doctor or health care provider for that and
- 0:28Speaker 1: any other health-related concerns you may have. Your reader is Mary.
- 0:32Speaker 1: Today I'll be reading various articles from different publications. First,
- 0:38Speaker 1: I'll be reading from the Harvard Women's Health Watch newsletter
- 0:41Speaker 1: published by Harvard Medical School. This issue is dated September 2026.
- 0:46Speaker 1: This is the lead article on the front page. Late
- 0:53Speaker 1: Start Hormone Therapy Safe or Risky? For older women seeking
- 1:00Speaker 1: relief from lingering menopause symptoms, it's vital to weigh the
- 1:06Speaker 1: pros and cons. Janet, age 62, has used hormone therapy
- 1:14Speaker 1: for years and is quick to gush about how it
- 1:17Speaker 1: eases her hot flashes. She wonders if her 70-year-old sister,
- 1:22Speaker 1: who deals with lingering menopause symptoms but hadn't previously used
- 1:26Speaker 1: hormone therapy, also called menopausal hormone therapy and hormone replacement therapy,
- 1:34Speaker 1: or HRT, could consider starting it now. But does initiating
- 1:41Speaker 1: hormone therapy many years after menopause help or hurt? It's
- 1:48Speaker 1: a thorny question, and one that more women may be
- 1:51Speaker 1: asking since the FDA removed black box warnings on hormone
- 1:56Speaker 1: therapy in November 2025, after experts decided the risks had
- 2:01Speaker 1: been overstated. There are guideposts to help make the decision,
- 2:08Speaker 1: but it's not a one-size-fits-all answer, says Dr. Joanne Manson,
- 2:13Speaker 1: a professor of women's health at Harvard Medical School and
- 2:16Speaker 1: chief of the Division of Preventive Medicine at Harvard-affiliated Brigham
- 2:21Speaker 1: and Women's Hospital. Most women who consider using hormone therapy, Dr.
- 2:27Speaker 1: Manson says, do so within 5 to 10 years after
- 2:32Speaker 1: entering menopause, which for American women happens at an average
- 2:36Speaker 1: age of 51. Indeed, guidelines from the Menopause Society recommend
- 2:42Speaker 1: that women starting hormone therapy do so before age 60
- 2:46Speaker 1: and within 10 years of menopause onset. Using hormone therapy
- 2:52Speaker 1: is usually of interest then because of the greater frequency
- 2:55Speaker 1: of hot flashes and night sweats women experience during that
- 2:59Speaker 1: time period, Dr. Manson says. Benefits and Risks Based on
- 3:07Speaker 1: Hormone Therapy Timing Hormone therapy involves taking either estrogen alone,
- 3:14Speaker 1: in women who've had a hysterectomy, or a combination of
- 3:18Speaker 1: estrogen and progesterone in women with a uterus. It's available
- 3:23Speaker 1: in various formulations including pills, patches, topical gels, or creams
- 3:29Speaker 1: and sprays. Topical versions are applied to the skin on
- 3:34Speaker 1: the upper arms, inner thighs, or abdomen. Some forms of
- 3:38Speaker 1: hormone therapy are used daily, while others, such as patches,
- 3:43Speaker 1: are applied weekly. Regardless of hormone therapy type, when you
- 3:50Speaker 1: start matters. Here's why. Estrogen receptors are located in cells
- 3:57Speaker 1: from head to toe, and beginning hormone therapy around menopause
- 4:01Speaker 1: when those receptors are still functioning optimally takes advantage of
- 4:06Speaker 1: that ability. Beginning earlier may also offer certain health benefits.
- 4:12Speaker 1: Some research indicates, for example, that starting hormone therapy near
- 4:17Speaker 1: menopause may support heart and brain health. We're not recommending
- 4:23Speaker 1: hormone therapy for prevention of heart disease, Dr. Manson says,
- 4:28Speaker 1: but some research suggests it may be protective by dilating
- 4:33Speaker 1: coronary arteries and decreasing inflammation in the blood vessels. Many
- 4:39Speaker 1: years after menopause, however, estrogen receptors around the body don't
- 4:44Speaker 1: function as well. So if you start hormone therapy later...
- 4:53Speaker 1: The reintroduction of estrogen may cause plaque accumulating in arteries
- 4:58Speaker 1: to erode or dislodge. Clots may form in a narrowed artery,
- 5:03Speaker 1: potentially triggering a heart attack or stroke. With menopause, there
- 5:08Speaker 1: are also major changes in how the brain uses fuel, Dr.
- 5:13Speaker 1: Manson says. Because of this, starting hormone therapy after age
- 5:19Speaker 1: 65 can be detrimental to brain function and slightly raising
- 5:23Speaker 1: the risk of dementia. This is not the case when
- 5:27Speaker 1: hormone therapy is started earlier in menopause, she says. Benefits
- 5:34Speaker 1: of Hormone Therapy After 65 That said, late-start hormone therapy,
- 5:42Speaker 1: in addition to relieving stubborn, pervasive hot flashes and night sweats,
- 5:47Speaker 1: does offer a distinct benefit to some postmenopausal women. Dr.
- 5:52Speaker 1: Manson says. Evidence suggests it can protect bone health, especially
- 5:58Speaker 1: in women with osteopenia, osteoporosis, or strong risk factors for
- 6:04Speaker 1: these bone thinning conditions, such as family history or earlier fractures.
- 6:11Speaker 1: This is a group of women where a case can
- 6:13Speaker 1: be made to either continue hormone therapy longer term or
- 6:18Speaker 1: to start it later. after very careful decision-making to account
- 6:22Speaker 1: for a woman's risk factor profile, she says. It requires
- 6:27Speaker 1: personalized and shared decision-making. Women who do begin hormone therapy
- 6:34Speaker 1: long after menopause should avoid oral estrogen and opt instead
- 6:40Speaker 1: for a skin patch, gel, or spray, Dr. Manson notes.
- 6:44Speaker 1: These methods bypass the liver and where clotting factors are made,
- 6:49Speaker 1: lowering the risk of blood clots compared to oral estrogen.
- 6:54Speaker 1: Versions applied to the skin are just as effective for
- 6:58Speaker 1: treating hot flashes and night sweats and for bone health
- 7:02Speaker 1: and other benefits, she says. The evidence to date indicates
- 7:06Speaker 1: they're a better option, especially in women with cardiovascular risk
- 7:11Speaker 1: factors such as obesity and diabetes. When is it too
- 7:20Speaker 1: late to start hormone therapy? While there is no hard
- 7:24Speaker 1: and fast rule, there is an age that should be
- 7:27Speaker 1: considered especially risky to start hormone therapy, says Dr. Joanne Manson,
- 7:32Speaker 1: a professor of women's health at Harvard Medical School. At
- 7:37Speaker 1: 70 and older, women should avoid initiating the treatment, even
- 7:42Speaker 1: if they're dealing with lingering hot flashes or night sweats.
- 7:46Speaker 1: Research indicates women in this group face a risk of
- 7:50Speaker 1: cardiovascular problems twice or even three times that of women
- 7:55Speaker 1: who don't use hormone therapy or those who begin using
- 7:59Speaker 1: it closer to menopause. It's still best to be below
- 8:03Speaker 1: age 60 and within 10 years of the onset of
- 8:07Speaker 1: menopause when you start hormone therapy, Dr. Manson says. But
- 8:12Speaker 1: a woman in her 60s might still be a candidate,
- 8:15Speaker 1: depending on her risk factors and for heart disease, stroke,
- 8:20Speaker 1: estrogen-sensitive cancers, and osteoporosis. If you're well beyond menopause and
- 8:27Speaker 1: interested in pursuing hormone therapy for the first time, Dr.
- 8:32Speaker 1: Manson suggests these approaches. Visit the Menopause Society. Their online
- 8:39Speaker 1: address is www.health.harvard.edu slash n-a-m-s to find a practitioner near
- 8:51Speaker 1: you who specializes in menopause care. Discuss it with your
- 8:56Speaker 1: primary care physician, internist, gynecologist, or another doctor who knows
- 9:02Speaker 1: you well. It doesn't have to be a specialist, she says.
- 9:08Speaker 1: I'm going to change now and read from Healthy Years
- 9:12Speaker 1: newsletter published by UCLA Health This issue is dated March 2026.
- 9:17Speaker 1: Empowered Vaccine Decisions Knowing the facts about mRNA vaccines can
- 9:27Speaker 1: help you make choices that protect your health, independence, and
- 9:31Speaker 1: quality of life as you age. With so much information
- 9:37Speaker 1: and misinformation about mRNA vaccines, it's not always easy to
- 9:43Speaker 1: sort out what's true. This article clears up common concerns
- 9:48Speaker 1: so you can be better informed and ready to talk
- 9:51Speaker 1: with your health care provider about vaccine decisions. What are
- 9:58Speaker 1: mRNA vaccines? vaccines? Messenger RNA. mRNA vaccines. Use a small
- 10:08Speaker 1: piece of genetic code to teach cells to make a
- 10:12Speaker 1: harmless protein that triggers the immune system to produce antibodies.
- 10:19Speaker 1: If a vaccinated person encounters the real virus later, the
- 10:23Speaker 1: immune system responds quickly, lowering the risk of severe illness.
- 10:28Speaker 1: Unlike traditional vaccines made with dead or weakened viruses, mRNA
- 10:34Speaker 1: vaccines contain no live virus and cannot cause disease. Some
- 10:42Speaker 1: people worry about the safety of these vaccines, given how
- 10:45Speaker 1: quickly they were developed during the pandemic. In reality, mRNA
- 10:51Speaker 1: technology has been studied for more than 20 years. Otto Yang, MD,
- 10:58Speaker 1: of the UCLA Division of Infectious Diseases, explains, The mRNA
- 11:04Speaker 1: vaccine was not experimental, nor was it suddenly foisted on
- 11:09Speaker 1: the public. It had already been shown to be safe
- 11:12Speaker 1: and capable of triggering strong immune responses. Because they can
- 11:18Speaker 1: be designed and produced quickly, mRNA vaccines were ideally suited
- 11:23Speaker 1: for rollout during the pandemic to protect public health. Concerns
- 11:30Speaker 1: that mRNA vaccines could alter DNA or cause cancer are
- 11:35Speaker 1: also unfounded. As Dr. Yang notes, the mRNA vaccines do
- 11:41Speaker 1: not alter a person's genetic code or increase cancer risk.
- 11:46Speaker 1: DNA is a master code in a cell, while mRNA
- 11:50Speaker 1: is a temporary message that's quickly broken down and discarded.
- 11:56Speaker 1: This technology is well understood, and claims about microchips, sterility,
- 12:02Speaker 1: or immune system harm are also unfounded. Why Regular Vaccines
- 12:10Speaker 1: Are Recommended As we grow older, our immune systems become
- 12:14Speaker 1: less equipped to fight infections like COVID-19 and the flu.
- 12:20Speaker 1: Even the healthiest, most active older adults face increased risks
- 12:24Speaker 1: of severe illness simply due to age, making it crucial
- 12:28Speaker 1: to understand the real-world benefits of vaccination and the need
- 12:33Speaker 1: for regular vaccinations in some cases. As Dr. Yang explains it,
- 12:39Speaker 1: As the immune systems naturally become weaker, it can be
- 12:42Speaker 1: harder for the body to respond to any vaccine, not
- 12:46Speaker 1: just mRNA vaccines. This is why some vaccines are recommended yearly.
- 12:54Speaker 1: In addition to aging, frailty and chronic illnesses like diabetes
- 12:59Speaker 1: can weaken a person's immune system, making it harder for
- 13:03Speaker 1: the body to fight infections or respond fully to vaccines. Moreover,
- 13:08Speaker 1: Some medical treatments for autoimmune diseases, including rheumatoid arthritis and
- 13:14Speaker 1: Crohn's disease, are designed to intentionally dampen the immune system,
- 13:20Speaker 1: which also can make vaccines less effective. However, Dr. Yang
- 13:25Speaker 1: stresses these same health conditions also raise the risk of
- 13:29Speaker 1: getting very sick or dying from COVID-19. For this reason,
- 13:35Speaker 1: it's even more important for people with these health issues
- 13:38Speaker 1: to get vaccinated. Key Drivers of the Aging Immune System
- 13:47Speaker 1: Two main biological changes, immunosenescence and inflammaging, drive immune decline
- 13:56Speaker 1: as we age. Immunosenescence is when the immune system weakens
- 14:01Speaker 1: and becomes less able to fight infections. Inflammaging is the
- 14:07Speaker 1: tendency for the body to be in a constant state
- 14:11Speaker 1: of low-level inflammation. These two conditions often happen side by
- 14:16Speaker 1: side and can make each other worse. As the immune
- 14:21Speaker 1: system gets weaker, immunosenescence, it struggles to clear out old,
- 14:27Speaker 1: damaged cells, which leads to more inflammation At the same time,
- 14:34Speaker 1: this constant inflammation can further weaken and disrupt the immune system. Together,
- 14:40Speaker 1: they increase the risk of infections, chronic diseases, and other
- 14:44Speaker 1: health problems commonly seen in older adults. This means that
- 14:51Speaker 1: older adults can face a higher risk of serious illness
- 14:54Speaker 1: from infections like the flu and COVID-19. However, if vaccines
- 15:04Speaker 1: are meant to train the immune system, it seems logical
- 15:08Speaker 1: to question why repeated vaccines might be needed in such cases. Dr.
- 15:14Speaker 1: Yang elaborates, immune protection from both the vaccine and from
- 15:19Speaker 1: having had COVID-19 only lasts a few months. This isn't
- 15:24Speaker 1: a flaw of the vaccine but rather a result of
- 15:27Speaker 1: how the immune system responds to this particular virus. That's
- 15:32Speaker 1: why someone can get COVID-19 more than once and why
- 15:37Speaker 1: regular boosters are recommended to help maintain protection. Viruses also
- 15:44Speaker 1: can mutate rapidly, creating new versions or variants that may
- 15:50Speaker 1: partly escape the immune protection from previous vaccination or infection.
- 15:56Speaker 1: This means people can get sick again, even if they've
- 15:59Speaker 1: already had COVID-19 before. or been vaccinated. Updated booster shots
- 16:05Speaker 1: are developed to match the most common or harmful variants
- 16:09Speaker 1: and help renew immunity, similar to how the yearly flu
- 16:13Speaker 1: shot is updated for new strains. These evolving viruses make
- 16:19Speaker 1: repeated vaccination especially important for older adults and those at
- 16:24Speaker 1: increased risk. Safety. What to know and expect. The safety
- 16:32Speaker 1: record for mRNA vaccines is excellent. Typical side effects, such
- 16:38Speaker 1: as sore arm, mild fever or fatigue, are short-lived and
- 16:44Speaker 1: often milder in older adults. Dr. Yang notes, people who
- 16:49Speaker 1: are older or have weaker immune systems are actually less
- 16:53Speaker 1: likely to have these side effects since they stem from
- 16:57Speaker 1: immune activation. which may be less vigorous in older adults.
- 17:02Speaker 1: Serious reactions such as heart inflammation or stroke are extremely
- 17:07Speaker 1: rare and far more likely to occur from the virus
- 17:11Speaker 1: itself than from the vaccine. For people with chronic diseases
- 17:18Speaker 1: like diabetes, obesity, or heart disease, the benefits of vaccination
- 17:24Speaker 1: far outweigh the risks. Talk with your doctor about which
- 17:28Speaker 1: vaccines are right for you and what side effects to expect.
- 17:33Speaker 1: Understanding them in advance can help you feel more confident
- 17:37Speaker 1: before you get vaccinated. What you can do. Dr. Yang
- 17:44Speaker 1: and solid scientific evidence debunk several common myths. mRNA vaccines
- 17:52Speaker 1: do not alter DNA. The vaccine's genetic material never enters
- 17:57Speaker 1: the cell's nucleus where DNA resides and is quickly broken down.
- 18:03Speaker 1: There is no evidence that mRNA vaccines cause cancer, infertility,
- 18:09Speaker 1: or long-term immune harm. The vaccines contain no microchips, tracking devices,
- 18:17Speaker 1: or data-collecting technology. Serious side effects such as heart inflammation,
- 18:24Speaker 1: are exceedingly rare and far less likely than complications from
- 18:29Speaker 1: COVID-19 infection. You cannot get COVID-19 from an mRNA vaccine
- 18:36Speaker 1: as it contains no live virus. And next, some research
- 18:45Speaker 1: news briefs that may be of interest. GLP-1 drugs cut
- 18:52Speaker 1: heart failure risks. A large analysis published in JAMA explained
- 18:58Speaker 1: how the widely used weight loss and diabetes drugs semaglutide, ozempic,
- 19:05Speaker 1: and wagovi, and tirzepatide, monjaro, and zepbound, affect people living
- 19:12Speaker 1: with obesity-related heart failure with preserved ejection fraction HFPEF and
- 19:20Speaker 1: type 2 diabetes. Using medical data from over 97,000 adults
- 19:26Speaker 1: across the U.S. between 2018 and 2024, researchers compared those
- 19:33Speaker 1: starting semaglutide, tirzepatide, or cetagliptin, an older diabetes medication used
- 19:41Speaker 1: as a placebo control, and followed them for up to
- 19:45Speaker 1: one year to track deaths and hospitalizations due to to
- 19:50Speaker 1: heart failure. The study found that both semaglutide and tirzepatide
- 19:56Speaker 1: users had dramatically lower rates of hospitalization or death compared
- 20:02Speaker 1: with those on cetagliptin. Semaglutide was linked to a 42%
- 20:08Speaker 1: reduction in risk, while terzepatide's risk reduction was about 58%.
- 20:15Speaker 1: The benefits were consistent across groups, and when the two
- 20:21Speaker 1: drugs were compared directly, they performed nearly the same. Participants
- 20:27Speaker 1: also tolerated the drugs well, with no significant safety issues
- 20:32Speaker 1: identified during follow-up. HFPEF, often driven by obesity and diabetes,
- 20:40Speaker 1: has long lacked effective therapies. These findings point to a
- 20:44Speaker 1: paradigm shift. GLP-1 medications not only help with weight loss
- 20:50Speaker 1: and blood sugar control, but also substantially cut the risk
- 20:56Speaker 1: of serious heart complications in people with obesity-related heart failures.
- 21:07Speaker 1: And next, blood tests may enable earlier ALS diagnosis. A
- 21:14Speaker 1: UCLA health study published in Genome Medicine has found that
- 21:19Speaker 1: a simple, non-invasive blood test measuring cell-free DNA could help
- 21:26Speaker 1: diagnose amyotrophic lateral sclerosis, ALS, earlier and more accurately. The
- 21:35Speaker 1: study examined fragments of cell-free DNA released into the bloodstream
- 21:41Speaker 1: from dying cells as a potential biomarker for ALS. Using
- 21:47Speaker 1: machine learning models, researchers analyzed DNA from blood samples of
- 21:52Speaker 1: ALS patients and healthy participants. The test was able to
- 21:58Speaker 1: clearly distinguish between those with ALS and those without. as
- 22:03Speaker 1: well as from individuals with other neurological conditions, a task
- 22:08Speaker 1: current biomarkers struggle with. It also provided clues about disease
- 22:15Speaker 1: severity by detecting signals from multiple tissue types, including nerve, muscle,
- 22:21Speaker 1: and immune cells. According to UCLA researchers, cell-free DNA has
- 22:28Speaker 1: distinct signatures caused by the natural process of DNA methylation,
- 22:34Speaker 1: which is altered by ALS and regulates gene expression. Their
- 22:40Speaker 1: model effectively discriminated between ALS patients, healthy individuals, and those
- 22:47Speaker 1: with other neurological conditions, allowing insights into disease progression and severity.
- 22:55Speaker 1: These findings suggest the test could someday help neurologists rule
- 23:00Speaker 1: out other diseases and identify ALS earlier, improving treatment opportunities
- 23:06Speaker 1: and potentially prolonging life expectancy. In the planning stages are
- 23:12Speaker 1: larger and more diverse clinical trials to validate the test
- 23:16Speaker 1: before clinical use. And next, nuts and seeds do not
- 23:24Speaker 1: increase diverticulitis risk. A large study published in the journal
- 23:30Speaker 1: Annals of Internal Medicine explored how diet influences the development
- 23:35Speaker 1: of diverticulitis in women over time. The study enrolled 29,916
- 23:41Speaker 1: women aged 35 to 74 across the United States and
- 23:48Speaker 1: Puerto Rico who had no previous history of diverticulitis, cancer,
- 23:54Speaker 1: or inflammatory bowel disease. Participants completed food frequency questionnaires and
- 24:01Speaker 1: were followed for up to 20 years. Over the course
- 24:05Speaker 1: of the study, 1,531 cases of new-onset diverticulitis were identified.
- 24:13Speaker 1: The key objective was to examine whether certain diets, particularly
- 24:18Speaker 1: those including nuts, seeds, and fruits with edible seeds, were
- 24:23Speaker 1: linked with diverticulitis risk. The results showed no association. Earlier
- 24:32Speaker 1: studies had found the same lack of association between consuming nuts, seeds,
- 24:37Speaker 1: and other particulate matter, pieces of food that can get
- 24:41Speaker 1: stuck in the colon, and diverticulitis in men. In this study,
- 24:46Speaker 1: women who followed high-quality dietary patterns such as the Dietary
- 24:51Speaker 1: Approaches to Stop Hypertension, the DASH diet, the Healthy Eating Index,
- 24:58Speaker 1: and the Alternative Mediterranean Diet, had significantly lower risks of
- 25:03Speaker 1: developing diverticulitis compared with those whose diets were least healthy.
- 25:09Speaker 1: The authors state that adhering to a nutritious, balanced, rich
- 25:14Speaker 1: diet rich in fruits, vegetables, whole grains, and lean proteins
- 25:20Speaker 1: can help reduce the risk of diverticulitis, while avoiding nuts
- 25:24Speaker 1: and seeds appears unnecessary. And next, a question and answer
- 25:33Speaker 1: in Ask Dr. Leonard. Question. My husband has early-stage dementia.
- 25:40Speaker 1: He's forgetful but still able to do a lot for himself.
- 25:44Speaker 1: He wants me to go to a doctor's appointment with him.
- 25:47Speaker 1: How can I best support him during this visit? Answer.
- 25:53Speaker 1: When your husband still manages most daily activities but struggles
- 25:57Speaker 1: with forgetfulness or repetition... Your presence can make the visit
- 26:02Speaker 1: much more effective, if handled with sensitivity and respect. Before
- 26:08Speaker 1: the appointment, helping him prepare by listing health concerns, memory changes,
- 26:14Speaker 1: or medication issues is tremendously useful. Encourage him to create
- 26:19Speaker 1: this list so he feels actively involved in his own care.
- 26:24Speaker 1: Bringing a current medication list and any recent test results
- 26:29Speaker 1: ensures that important details aren't overlooked. During the visit, it's
- 26:35Speaker 1: important to let your husband speak for himself as much
- 26:38Speaker 1: as possible. I find it most helpful when caregivers allow
- 26:43Speaker 1: the patient to share their experiences first, then step in
- 26:47Speaker 1: to clarify or fill in gaps only when needed. This
- 26:52Speaker 1: approach preserves his autonomy and helps maintain his trust in
- 26:57Speaker 1: both you and me as his physician. If he becomes
- 27:01Speaker 1: repetitive or uncertain, respond with patience and reassurance rather than correction.
- 27:08Speaker 1: A calm, compassionate tone helps keep the appointment productive and
- 27:13Speaker 1: comfortable for everyone. Afterwards, reviewing what was discussed and writing
- 27:19Speaker 1: down instructions or next steps can prevent confusion later. And perhaps,
- 27:26Speaker 1: most importantly, continuing to approach his care as a partnership
- 27:31Speaker 1: rather than taking over, supports both his dignity and emotional well-being.
- 27:41Speaker 1: And with that, we conclude the Women's Health Corner for today.
- 27:45Speaker 1: Your reader has been Mary. If you have any questions, comments,
- 27:49Speaker 1: or suggestions concerning this program, please call us in our
- 27:53Speaker 1: Lexington studios at 859-422-4222 And now, please stay tuned to
- 28:01Speaker 1: Radio Eye for the continuation of our local broadcast. Thank
- 28:05Speaker 1: you for listening, and have a healthy and happy day.